Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
Milad Abdalla, Medical Laboratory Technologist at Al Yalayis Government Transactions Center, shared a post on LinkedIn:
“Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
Accurate diagnostics start long before the sample reaches the analyzer. The pre‑analytical phase – especially the Order of Draw and proper Blood Culture collection – remains one of the most critical determinants of result integrity.
Why It Matters?
Additive carryover can alter results, delay diagnosis, and compromise patient safety. That’s why the CLSI sequence is the global benchmark for preventing contamination and ensuring reliable outcomes.
CLSI Order of Draw (Simplified)
- Blood Cultures — Always first to maintain sterility and avoid additive interference.
- Light Blue – Citrate — Coagulation tests requiring precise 1:9 ratio.
- Serum Tubes – Red/Gold/SST — Chemistry, serology, immunology.
- Green – Heparin — STAT chemistry and blood gases.
- Lavender – EDTA — CBC, HbA1c; collected late to avoid metal chelation interference.
- Grey – Fluoride/Oxalate — Glucose and lactate; strong inhibitors, so always last.
Blood Cultures – The First Line in Infection Diagnosis
Their accuracy depends on:
- Strict aseptic technique
- Correct blood volume
- Drawing them before any other tube
Key Takeaways
- Sterility first — Blood cultures always lead the sequence.
- Prevent additive carryover — Follow CLSI strictly.
- Volume accuracy — Especially for coagulation and cultures.
- Continuous competency — Phlebotomy excellence is a global responsibility.
By mastering these fundamentals, we elevate diagnostic accuracy and strengthen patient safety across healthcare systems worldwide.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026